B. Riley Boosts Celsius (NASDAQ:CELH) Price Target to $75.00

Key Points

• B. Riley has increased the price target for Celsius (NASDAQ:CELH) from $56.00 to $75.00, indicating a potential upside of 23.75% based on the stock's previous close.
• Sixteen analysts have rated Celsius with a Buy rating, with an average target price of $58.00, while Needham & Company and Roth Capital also recently updated their price targets to reflect positive outlooks.
• Celsius reported earnings of $0.47 per share for the quarter, exceeding consensus estimates by $0.24, with revenues showing an impressive year-over-year growth of 83.9%.

Celsius (NASDAQ:CELH - Get Free Report) had its target price hoisted by investment analysts at B. Riley from $56.00 to $75.00 in a research note issued on Tuesday,Benzinga reports. The brokerage presently has a "buy" rating on the stock. B. Riley's price objective suggests a potential upside of 23.75% from the company's previous close.

Other equities analysts also recently issued research reports about the stock. Needham & Company LLC lifted their price target on shares of Celsius from $55.00 to $60.00 and gave the company a "buy" rating in a report on Thursday, August 7th. Roth Capital reaffirmed a "buy" rating and set a $52.00 price target (up previously from $46.00) on shares of Celsius in a report on Thursday, June 26th. Wall Street Zen downgraded shares of Celsius from a "buy" rating to a "hold" rating in a report on Sunday, August 17th. Piper Sandler lifted their price target on shares of Celsius from $44.00 to $45.00 and gave the company an "overweight" rating in a report on Wednesday, June 4th. Finally, Truist Financial lifted their price objective on shares of Celsius from $55.00 to $65.00 and gave the company a "buy" rating in a research report on Monday, August 11th. Sixteen equities research analysts have rated the stock with a Buy rating, three have given a Hold rating and one has assigned a Sell rating to the company's stock. Based on data from MarketBeat.com, Celsius presently has an average rating of "Moderate Buy" and an average target price of $58.00.

Celsius Stock Performance

Shares of CELH traded down $2.27 on Tuesday, reaching $60.61. The company's stock had a trading volume of 1,468,173 shares, compared to its average volume of 8,091,375. The company has a debt-to-equity ratio of 0.68, a current ratio of 2.11 and a quick ratio of 1.76. The stock has a market capitalization of $15.63 billion, a P/E ratio of 163.65, a PEG ratio of 1.43 and a beta of 1.33. The stock's 50 day simple moving average is $50.13 and its two-hundred day simple moving average is $40.23. Celsius has a 12-month low of $21.10 and a 12-month high of $63.50.

Celsius (NASDAQ:CELH - Get Free Report) last issued its quarterly earnings results on Thursday, August 7th. The company reported $0.47 earnings per share for the quarter, beating the consensus estimate of $0.23 by $0.24. Celsius had a net margin of 7.91% and a return on equity of 36.88%. The business had revenue of $739.30 million for the quarter, compared to the consensus estimate of $632.13 million. During the same quarter in the previous year, the firm earned $0.28 earnings per share. The company's revenue for the quarter was up 83.9% on a year-over-year basis. Research analysts forecast that Celsius will post 0.89 earnings per share for the current fiscal year.

Insider Buying and Selling at Celsius

In related news, CFO Jarrod Langhans sold 5,000 shares of the business's stock in a transaction on Monday, August 18th. The shares were sold at an average price of $60.00, for a total value of $300,000.00. Following the sale, the chief financial officer owned 104,227 shares in the company, valued at approximately $6,253,620. The trade was a 4.58% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, major shareholder William H. Milmoe sold 100,000 shares of the business's stock in a transaction on Thursday, July 31st. The stock was sold at an average price of $47.50, for a total transaction of $4,750,000.00. Following the completion of the sale, the insider owned 17,717,770 shares in the company, valued at $841,594,075. This represents a 0.56% decrease in their position. The disclosure for this sale can be found here. Over the last three months, insiders have sold 1,116,141 shares of company stock worth $52,541,605. Company insiders own 2.20% of the company's stock.

Institutional Investors Weigh In On Celsius

Several institutional investors have recently modified their holdings of the stock. Westside Investment Management Inc. bought a new position in shares of Celsius during the 1st quarter valued at approximately $32,000. Summit Securities Group LLC purchased a new position in Celsius during the first quarter worth $34,000. MassMutual Private Wealth & Trust FSB boosted its stake in Celsius by 255.1% during the first quarter. MassMutual Private Wealth & Trust FSB now owns 1,044 shares of the company's stock worth $37,000 after buying an additional 750 shares during the period. Hantz Financial Services Inc. increased its position in Celsius by 1,476.0% during the second quarter. Hantz Financial Services Inc. now owns 788 shares of the company's stock valued at $37,000 after acquiring an additional 738 shares during the last quarter. Finally, UMB Bank n.a. raised its stake in shares of Celsius by 145.0% in the first quarter. UMB Bank n.a. now owns 1,426 shares of the company's stock valued at $51,000 after acquiring an additional 844 shares during the period. 60.95% of the stock is owned by institutional investors.

About Celsius

Celsius Holdings, Inc develops, processes, markets, distributes, and sells functional energy drinks and liquid supplements in the United States, Australia, New Zealand, Canadian, European, Middle Eastern, Asia-Pacific, and internationally. The company offers CELSIUS, a fitness drink or supplement designed to accelerate metabolism and burn body fat; various flavors and carbonated and non-carbonated functional energy drinks under the CELSIUS Originals and Vibe name, as well as functional energy drink under the CELSIUS Essentials and CELSIUS On-the-Go Powder names; and CELSIUS ready-to drink products.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.